Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity.
Saved in:
| Title: | Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity. |
|---|---|
| Authors: | Lam JS (AUTHOR), Benson MC (AUTHOR), O'Donnell MA (AUTHOR), Sawczuk A (AUTHOR), Gavazzi A (AUTHOR), Wechsler MH (AUTHOR), Sawczuk IS (AUTHOR), Lam, John S1 (AUTHOR), Benson, Mitchell C (AUTHOR), O'Donnell, Michael A (AUTHOR), Sawczuk, Alexandra (AUTHOR), Gavazzi, Anna (AUTHOR), Wechsler, Michael H (AUTHOR), Sawczuk, Ihor S (AUTHOR) |
| Source: | Urologic Oncology. Sep2003, Vol. 21 Issue 5, p354-360. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
